Brian Hoit, MD
Cardiovascular Disease · Cleveland, OHNPI 1225054430
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $168,127 of the $207,119 with a category attached, or 81.2%. Philips North America LLC accounts for 96.4% of it on its own, with 16 other manufacturers making up the rest. Reporting peaked in 2020 at $85,853 and has fallen 91.2% since, to $7,514 in 2025. Among cardiovascular disease clinicians in OH with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 295 payments — averaging $702.10 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Philips North America LLC$200K
- Merck$5K
- Novartis$687
- Pfizer$555
- Johnson & Johnson$346
- ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$207
- plus $867 from 11 others
Across 8 payments — averaging $6259.57 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Lantheus Medical Imaging, Inc.$48K
- Takeda Pharmaceuticals U.S.A., Inc.$2K
What the payments were for
- Consulting fees$6,0693%
- Speaking & faculty fees$168,12781%
- Travel & lodging$25,92013%
- Food & beverage$7,0043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Philips North America LLC | 131 | $199,587 |
| Merck | 10 | $4,871 |
| Novartis | 36 | $687 |
| Pfizer | 40 | $555 |
| Johnson & Johnson | 23 | $346 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $207 |
| Lantheus Medical Imaging, Inc. | 8 | $177 |
| Abbott | 7 | $140 |
| AstraZeneca(2 entities) | 6 | $100 |
| E.r. Squibb & Sons, L.L.C. | 6 | $92 |
| Kiniksa Pharmaceuticals, Ltd. | 5 | $91 |
| Boehringer Ingelheim | 4 | $84 |
| Amgen | 4 | $70 |
| Sanofi-aventis U.S. LLC | 2 | $40 |
| Sanofi | 2 | $35 |
| Esperion Therapeutics, Inc. | 1 | $21 |
| Atricure, Inc. | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Educ Ultrasound$57,456
- (1658) Clinical Educ Ultrasound$43,121
- (7881) Ultrasound Und$41,500
- RS Ultrasound undiv$25,111
- US Undivided Serv$24,119
- Clin Educ US$6,449
- EPIQ CVx$128
How this compares
$207,119 in reported general payments places this provider in the 95th percentile of 827 cardiovascular disease providers in Ohio.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other cardiovascular disease in Cleveland
- Guilherme AttizzaniCleveland$1.3M
- Abraham LincoffCleveland$369K
- Oussama WazniCleveland$367K
- Ian NeelandCleveland$329K
- Mazen HannaCleveland$208K
- Steven NissenCleveland$149K
- Daniel CantillonCleveland$140K
- Serge HarbCleveland$134K
- Wael JaberCleveland$124K
- Milind DesaiCleveland$102K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.